Good Laboratory Practice (GLP) status of Asian countries and its implementation in non-clinical safety studies in pharmaceutical drug development-Reference-Cited by-同舟云学术

Good Laboratory Practice (GLP) status of Asian countries and its implementation in non-clinical safety studies in pharmaceutical drug development

Published:2009 Issue:5 Volume:34 Page:493-500
ISSN:0388-1350
Container-title:The Journal of Toxicological Sciences
language:en
Short-container-title:J. Toxicol. Sci.

Author:

Sasaki Madoka¹,Hinotsu Shiro¹,Kawakami Koji¹

Affiliation:

1. Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University

Publisher

Japanese Society of Toxicology

Subject

Toxicology

Link

http://www.jstage.jst.go.jp/article/jts/34/5/34_5_493/_pdf

Reference35 articles.

1. Abe, Y. (2006): GLP situation in Asia. Obe-lisk, 11, 4-5.

2. Cyranoski, D. (2008): Pharmaceutical futures: made in China? Nature, 455, 1168-1170.

3. The price of innovation: new estimates of drug development costs

4. EPC (2004a): European Parliament and Council, Directive 2004/9/EC of the European Parliament and of the Council of 11 February 2004 on the inspection and verification of good laboratory practice (GLP).

5. EPC (2004b): European Parliament and Council, Directive 2004/10/EC of the European Parliament and of the Council of 11 February 2004 on the harmonization of laws, regulations and administrative provision relating to the application of the principles of good laboratory practice and the verification of their applications for tests on chemical substances.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principles of Good Laboratory Practice (GLP);Biomedical Product Development: Bench to Bedside;2020

2. Accreditation and recognition programs in Brazil: current situation and perspectives;Accreditation and Quality Assurance;2013-04-18